Behavioral/neurophysiological investigation of effects of combining a quinolinic acid entopeduncular lesion with a fetal mesencephalic tissue transplant in striatum of the 6-OHDA hemilesioned rat.
Behavioral and electrophysiological methods were used to investigate the effects of combining a unilateral quinolinic acid lesion of the entopeduncular nucleus (QA/EP) with a striatal transplant of fetal ventral mesencephalic tissue in the 6-hydroxydopamine (6-OHDA) hemilesioned rat model for Parkinson's disease. The subjects were 6-OHDA-lesioned rats selected because their response to amphetamine treatment was a strongly biased rotation toward the side of the 6-OHDA lesion in the substantia nigra, at the expense of other evoked behaviors associated with amphetamine. Two experiments were performed. In the first, the motor effects of the QA/EP lesion alone and of the combination of QA/EP lesion with striatal transplant were determined by measuring six aspects of the motor response. In the second the electrophysiological effects of the two interventions on the responses of neurons in the subthalamic nucleus to amphetamine and apomorphine were determined in the 6-OHDA-lesioned rats. The results of the first experiment show that the QA/EP lesion by itself produced an attenuation of the rotation response and, simultaneously, an increase of oral stereotypy. They also show that the combination of QA/EP lesion with striatal transplant was more effective than the single intervention, inducing more attenuation of rotation and more oral stereotypy. The results of the second experiment show that the responses of subthalamic neurons to amphetamine in the behaving hemiparkinsonian rat with combined QA/EP lesion and transplant were larger than the responses in the hemiparkinsonian rat with the QA/EP lesion alone. However, even these larger responses in the rats with combined intervention were not as large as those recorded at the same time in the subthalamus in the opposite, intact, hemisphere. The results of the two experiments, both of which show enhanced motor and neuronal sensitivity to amphetamine after the combined intervention, suggest that such a multiple approach might prove more beneficial than a one-site intervention targeting either the EP or the striatum.
Olds
M E
ME
Division of Biology, California Institute of Technology, Pasadena, California 91125, USA. meo@caltech.edu
Jacques
D B
DB
Kpoyov
O
O
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001927:Brain Diseases / Q000139:chemically induced; D016380:Brain Tissue Transplantation; D003342:Corpus Striatum / Q000187:drug effects / Q000502:physiology / Q000637:transplantation; D018491:Dopamine Agonists / Q000494:pharmacology; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology; D004594:Electrophysiology; D020392:Entopeduncular Nucleus / Q000187:drug effects / Q000293:injuries / Q000502:physiology; D016332:Fetal Tissue Transplantation; D005333:Fetus; D007839:Functional Laterality; D007150:Immunohistochemistry; D008297:Male; D008636:Mesencephalon / Q000187:drug effects / Q000502:physiology / Q000637:transplantation*; D023421:Models, Animal; D009043:Motor Activity / Q000187:drug effects* / Q000502:physiology; D009474:Neurons / Q000187:drug effects / Q000473:pathology / Q000502:physiology; D010300:Parkinson Disease / Q000503:physiopathology*; D017378:Quinolinic Acid / Q000494:pharmacology; D051381:Rats; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D018491:Dopamine Agonists; D018765:Dopamine Uptake Inhibitors; D000661:Amphetamine; D014446:Tyrosine 3-Monooxygenase; D017378:Quinolinic Acid; D001058:Apomorphine